Democratizing hedge fund level analysis tools for everyone
About |
---|
PT Indofarma Tbk, together with its subsidiaries, manufactures and markets pharmaceutical products in Indonesia. The company manufactures, trades in, and distributes medicine and medical devices; extracts and herbals; and operates laboratory. The company was formerly known as PT Indofarma (Persero) Tbk PT Indofarma Tbk was founded in 1918 and is headquartered in Bekasi, Indonesia. PT Indofarma Tbk is a subsidiary of PT Bio Farma.. |
Info | Profile |
---|---|
Name | Indofarma Tbk. |
Sector | Healthcare |
Industry | Pharmaceuticals & Health Care Research |
Code | F2 |
Latest Quarterly | 09/30/2024 |
Name | Latest % | A Month Ago % |
---|---|---|
PT. Bio Farma (Persero) | 80.66 | 80.66 |
Public < 5% | 11.99 | 11.99 |
PT. Asabri (Persero) - Dapen Tni | 7.34 | 7.34 |
Classification | Latest % | Previous % |
---|---|---|
Institution | 88.01 | 88.01 |
Retail | 11.99 | 11.99 |
Individual | 0.0 | 0.0 |
Management | 0.0 | 0.0 |
Revenue Source | 2023 | 2022 |
---|---|---|
Medicine | 65.3% | 48.6% |
Medical Devices & Others | 34.7% | 51.4% |
Others | 0.0% | 0.0% |
Engineering Pharmaceutical | 0.0% | 0.0% |
Revenue Region | 2023 | 2022 |
---|---|---|
Indonesia | 100.0% | 100.0% |
Others | 0.0% | 0.0% |
Year | DPS | Yield [%] |
---|
Timeframe | Performance |
---|---|
1W % | -3.1 |
1Mo % | -45.2 |
3Mo % | -68.8 |
1Yr % | -79.7 |
Pivot | Points |
---|---|
R2 | 176 |
R1 | 158 |
S1 | 124 |
S2 | 108 |
Link download Laporan Keuangan emiten
Stock | PER | Market Cap | EV | Revenue | EBITDA | Net Profit |
---|---|---|---|---|---|---|
INAF | -1.76 | 391 B | 2.11 T | 184 B | -154 B | -222 B |
KLBF | 21.78 | 58.13 T | 58.24 T | 32,628 B | 5,069 B | 3,241 B |
SIDO | 13.45 | 17.40 T | 16.99 T | 3,919 B | 1,577 B | 1,171 B |
TSPC | 7.93 | 11.95 T | 10.82 T | 13,655 B | 2,114 B | 1,448 B |
SOHO | 18.53 | 8.25 T | 10.52 T | 10,058 B | 618 B | 463 B |
KAEF | -4.88 | 2.39 T | 12.98 T | 10,486 B | -9 B | -562 B |